It’s not that Yatai Group doesn’t want to buy it.

In the 24 years since its listing, Yatai has grown from a small state-owned tea company with a net asset of less than 100 million yuan to a current net asset of 14.5 billion yuan, with 6 high-quality assets including cement, biomedicine, real estate, commerce, coal, and financial investment.

For 11 consecutive years, it has been rated as one of the top 500 domestic companies, fourth among the top 20 domestic building materials companies, and 64th among the top 100 domestic pharmaceutical manufacturing industries. The pharmaceutical industry has become a first-class pharmaceutical company. Yatai management's management and development philosophy

Keeping pace with the times is indispensable.

Due to various reasons, Yatai's stock price is seriously undervalued, which is an excellent buying opportunity for value investors.